Product Information
GABAPENTIN 250 MG/5 ML SOLN is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0825 per ML under NDC 59762505007. Its NADAC has been published 199 times since Sep 7, 2022.
Strength
250 mg/5mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762505007
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Authorized Generic (NDA)
FDA Application
NDA021129On Market Since
7/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 250 MG/5 ML SOLN has been published 199 times since Sep 7, 2022, and over the history we have for it it has declined 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0825 per ML |
|---|---|
| All-time high | $0.1379 (Sep 13, 2023) |
| All-time low | $0.0768 (Nov 20, 2024) |
| 52-week high | $0.0895 |
| 52-week low | $0.0825 |
| Median price | $0.0948 |
| Average price | $0.1012 |
| Largest weekly change | -23.5% (Apr 17, 2024) |
| Weeks tracked | 199 |
| Tracking since | Sep 7, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 250 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 250 MG/5 ML SOLN, manufactured by Mylan Pharmaceuticals Inc., is $0.0825 per ML (NDC 59762505007), effective Jun 24, 2026.
How has the price of GABAPENTIN 250 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has declined 6.2%. It has been tracked across 199 weekly CMS publications since Sep 7, 2022.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 250 MG/5 ML SOLN?
Since Sep 7, 2022, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has ranged from a low of $0.0768 (Nov 20, 2024) to a high of $0.1379 (Sep 13, 2023), with a median of $0.0948 per ML.
Are there cheaper alternatives to GABAPENTIN 250 MG/5 ML SOLN?
2 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 250 MG/5 ML SOLN, but none are currently priced below it.
Who manufactures GABAPENTIN 250 MG/5 ML SOLN?
GABAPENTIN 250 MG/5 ML SOLN (NDC 59762505007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification